Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 54 (1) , 87-97
- https://doi.org/10.1016/0090-1229(90)90008-e
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients.Journal of Clinical Investigation, 1987
- Anticardiolipin antibodies in unselected autoimmune rheumatic disease patientsClinical Immunology and Immunopathology, 1987
- Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.Journal of Clinical Investigation, 1987
- Detection of anti-histone activity in sera of patients with monoclonal gammopathiesClinical Immunology and Immunopathology, 1987
- Ocular immune reactants in patients dying with systemic lupus erythematosusClinical Immunology and Immunopathology, 1985
- Treatment of experimental myasthenia gravis with cyclosporin AClinical Immunology and Immunopathology, 1985
- ANTI-DNA ANTIBODY IDIOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1984
- Polyspecificity of Monoclonal Lupus Autoantibodies Produced by Human-Human HybridomasNew England Journal of Medicine, 1983
- Cyclosporin A: Alterations of the Cellular Immune Response in S-Antigen-Induced Experimental Autoimmune UveitisInternational Archives of Allergy and Immunology, 1983
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981